Kohsuke Imai

13.9k total citations
232 papers, 6.6k citations indexed

About

Kohsuke Imai is a scholar working on Immunology, Molecular Biology and Hematology. According to data from OpenAlex, Kohsuke Imai has authored 232 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 109 papers in Immunology, 64 papers in Molecular Biology and 54 papers in Hematology. Recurrent topics in Kohsuke Imai's work include Immunodeficiency and Autoimmune Disorders (73 papers), Immune Cell Function and Interaction (35 papers) and T-cell and B-cell Immunology (28 papers). Kohsuke Imai is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (73 papers), Immune Cell Function and Interaction (35 papers) and T-cell and B-cell Immunology (28 papers). Kohsuke Imai collaborates with scholars based in Japan, United States and France. Kohsuke Imai's co-authors include Shigeaki Nonoyama, Fumio Itoh, Kei Nakachi, Kaname Kawajiri, M Adachi, Tomohiro Morio, Anne Durandy, M Toyota, Hans D. Ochs and Alain Fischer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Kohsuke Imai

221 papers receiving 6.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kohsuke Imai Japan 40 3.3k 2.4k 1.0k 998 781 232 6.6k
Derek W. Abbott United States 36 5.2k 1.6× 2.9k 1.2× 938 0.9× 670 0.7× 919 1.2× 67 7.4k
Cornelis L. Verweij Netherlands 34 2.4k 0.7× 2.0k 0.8× 1.4k 1.3× 572 0.6× 449 0.6× 62 6.1k
Richard J. Riese United States 36 1.6k 0.5× 2.2k 0.9× 1.1k 1.1× 500 0.5× 629 0.8× 76 7.2k
Naoto Itoh Japan 26 4.2k 1.3× 3.5k 1.4× 1.1k 1.1× 1.3k 1.3× 938 1.2× 50 7.9k
Katherine A. Siminovitch Canada 52 3.6k 1.1× 4.2k 1.7× 1.2k 1.2× 1.6k 1.6× 753 1.0× 136 8.8k
Kenzaburo Tani Japan 38 2.4k 0.8× 1.4k 0.6× 1.2k 1.1× 1.1k 1.1× 406 0.5× 225 5.4k
David W. Scott United States 49 2.8k 0.9× 4.2k 1.7× 1.5k 1.5× 925 0.9× 342 0.4× 287 8.0k
Fabien Calvo France 45 3.3k 1.0× 842 0.3× 2.3k 2.2× 719 0.7× 547 0.7× 160 6.7k
Robert Hromas United States 55 6.1k 1.9× 2.7k 1.1× 2.7k 2.6× 1.2k 1.2× 493 0.6× 207 10.4k
David Allman United States 57 3.3k 1.0× 6.7k 2.7× 2.4k 2.3× 652 0.7× 471 0.6× 112 11.0k

Countries citing papers authored by Kohsuke Imai

Since Specialization
Citations

This map shows the geographic impact of Kohsuke Imai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kohsuke Imai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kohsuke Imai more than expected).

Fields of papers citing papers by Kohsuke Imai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kohsuke Imai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kohsuke Imai. The network helps show where Kohsuke Imai may publish in the future.

Co-authorship network of co-authors of Kohsuke Imai

This figure shows the co-authorship network connecting the top 25 collaborators of Kohsuke Imai. A scholar is included among the top collaborators of Kohsuke Imai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kohsuke Imai. Kohsuke Imai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nambu, Ryusuke, Kunihiko Moriya, Atsuko Nakazawa, et al.. (2025). JAK inhibitor ameliorates inflammatory bowel disease in a patient with IKZF1 haploinsufficiency. Clinical Immunology. 274. 110470–110470. 1 indexed citations
2.
Moriya, Kunihiko, Kanako Mitsui‐Sekinaka, Akifumi Endo, et al.. (2023). Clinical practice guideline for activated phosphatidyl inositol 3-kinase-delta syndrome in Japan. Immunological Medicine. 46(4). 153–157. 6 indexed citations
3.
Kawaguchi, Hiroyuki, et al.. (2023). A case of suspected lupus anticoagulant‐hypoprothrombinemia syndrome in a boy due to mycoplasma infection. Pediatrics International. 65(1). e15592–e15592. 1 indexed citations
4.
Arakawa, Yuki, Daisuke Hasegawa, Takako Miyamura, et al.. (2022). Postchemotherapy immune status in infants with acute lymphoblastic leukemia: A report from the JPLSG MLL‐10 trial. Pediatric Blood & Cancer. 69(10). e29772–e29772.
5.
Yamashita, Motoi, Hye Sun Kuehn, Kazuki Okuyama, et al.. (2021). A variant in human AIOLOS impairs adaptive immunity by interfering with IKAROS. Nature Immunology. 22(7). 893–903. 40 indexed citations
6.
Kajiho, Yuko, Chie Takahashi, Shoichiro Kanda, et al.. (2021). An infant with X‐linked anhidrotic ectodermal dysplasia with immunodeficiency presenting with Pneumocystis pneumonia: A case report. SHILAP Revista de lepidopterología. 9(11). e05093–e05093. 3 indexed citations
7.
Hoshino, Akihiro, Hirokazu Kanegane, Masanori Nishi, et al.. (2019). Identification of autoantibodies using human proteome microarrays in patients with IPEX syndrome. Clinical Immunology. 203. 9–13. 12 indexed citations
8.
Tomizawa, Daisuke, Noriko Mitsuiki, Yuki Aoki, et al.. (2018). Hematopoietic cell transplantation for myeloid/ NK cell precursor acute leukemia in second remission. Clinical Case Reports. 6(6). 1023–1028. 3 indexed citations
9.
Jolles, Stephen, Mikhail Rojavin, John‐Philip Lawo, et al.. (2018). Long-Term Efficacy and Safety of Hizentra® in Patients with Primary Immunodeficiency in Japan, Europe, and the United States: a Review of 7 Phase 3 Trials. Journal of Clinical Immunology. 38(8). 864–875. 21 indexed citations
10.
Tamura, Akihiro, Nobuyuki Yamamoto, Kenji Kishimoto, et al.. (2018). Hematopoietic cell transplantation for asymptomatic X-linked lymphoproliferative syndrome type 1. Allergy Asthma and Clinical Immunology. 14(1). 82–82. 2 indexed citations
11.
Rawat, Amit, Ankur Kumar Jindal, Madhubala Sharma, et al.. (2018). Clinical and molecular features of X-linked hyper IgM syndrome – An experience from North India. Clinical Immunology. 195. 59–66. 11 indexed citations
12.
Mitsui‐Sekinaka, Kanako, Kohsuke Imai, Hiroki Sato, et al.. (2015). Clinical features and hematopoietic stem cell transplantations for CD40 ligand deficiency in Japan. Journal of Allergy and Clinical Immunology. 136(4). 1018–1024. 32 indexed citations
13.
Zahn, Astrid, Anne‐Marie Patenaude, Stephen P. Methot, et al.. (2014). Activation induced deaminase C-terminal domain links DNA breaks to end protection and repair during class switch recombination. Proceedings of the National Academy of Sciences. 111(11). E988–97. 41 indexed citations
14.
Imai, Kohsuke, et al.. (2013). Satisfaction after the Malone antegrade continence enema procedure in patients with spina bifida. Spinal Cord. 52(1). 54–57. 18 indexed citations
15.
Keerthikumar, Shivakumar, Rajesh Raju, YL Ramachandra, et al.. (2009). Prediction of Candidate Primary Immunodeficiency Disease Genes Using a Support Vector Machine Learning Approach. DNA Research. 16(6). 345–351. 19 indexed citations
16.
Imai, Kohsuke, Nadia Catalan, Alessandro Plebani, et al.. (2003). Hyper-IgM syndrome type 4 with a B lymphocyte–intrinsic selective deficiency in Ig class-switch recombination. Journal of Clinical Investigation. 112(1). 136–142. 90 indexed citations
17.
Catalan, Nadia, Françoise Selz, Kohsuke Imai, et al.. (2003). The Block in Immunoglobulin Class Switch Recombination Caused by Activation-Induced Cytidine Deaminase Deficiency Occurs Prior to the Generation of DNA Double Strand Breaks in Switch μ Region. The Journal of Immunology. 171(5). 2504–2509. 78 indexed citations
18.
Morita, Itsuro, Takehiro Tsuritani, Noboru Yoshikane, et al.. (2002). 100 % Spectral-Efficient 25 × 42.7 Gbit/s Transmission Using Asymmetrically Filtered CS-RZ Signal and a Novel Crosstalk Suppressor. European Conference on Optical Communication. 5. 1–2. 3 indexed citations
19.
Adachi, M & Kohsuke Imai. (2002). The proapoptotic BH3-only protein BAD transduces cell death signals independently of its interaction with Bcl-2. Cell Death and Differentiation. 9(11). 1240–1247. 47 indexed citations
20.
Kageshita, Toshiro, et al.. (1985). Immunohistological detection of human malignant melanoma using monoclonal antibody to a melanoma-associated antigen. Archives of Dermatological Research. 277(4). 334–336. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Derek W. Abbott Breakdown of academic impact, for papers by Cornelis L. Verweij Breakdown of academic impact, for papers by Richard J. Riese Breakdown of academic impact, for papers by Naoto Itoh Breakdown of academic impact, for papers by Katherine A. Siminovitch Breakdown of academic impact, for papers by Kenzaburo Tani Breakdown of academic impact, for papers by David W. Scott Breakdown of academic impact, for papers by Fabien Calvo Breakdown of academic impact, for papers by Robert Hromas Breakdown of academic impact, for papers by David Allman
Rankless by CCL
2026